Fagron NV (FAGRO)

Currency in EUR
20.65
-0.05(-0.24%)
Closed·
FAGRO Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
FAGRO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.5520.70
52 wk Range
15.1423.50
Key Statistics
Prev. Close
20.7
Open
20.6
Day's Range
20.55-20.7
52 wk Range
15.14-23.5
Volume
69.13K
Average Volume (3m)
68.49K
1-Year Change
8.6%
Book Value / Share
6.87
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FAGRO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.84
Upside
+20.29%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Fagron NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell

Fagron NV Company Profile

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Employees
3989
Market
Belgium

Compare FAGRO to Peers and Sector

Metrics to compare
FAGRO
Peers
Sector
Relationship
P/E Ratio
17.7x21.0x−0.6x
PEG Ratio
1.830.200.00
Price/Book
3.0x1.5x2.6x
Price / LTM Sales
1.6x0.7x3.3x
Upside (Analyst Target)
21.1%27.4%40.0%
Fair Value Upside
Unlock16.7%4.7%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 24.84
(+20.29% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.18%
Dividend Yield
1.18%
Industry Median 0.77%
Annualised payout
0.25
Paid annually
5-Years Growth
+34.34%
Growth Streak

Earnings

Latest Release
Aug 01, 2025
EPS / Forecast
0.63 / --
Revenue / Forecast
476.13M / 234.90M
EPS Revisions
Last 90 days

FAGRO Income Statement

People Also Watch

646.20
ASML
+1.84%
272.00
ESLX
0.00%
27.13
DAST
+0.63%
72.24
TEPRF
-0.28%
183.12
AIRP
-0.10%

FAQ

What Stock Exchange Does Fagron Trade On?

Fagron is listed and trades on the Brussels Stock Exchange stock exchange.

What Is the Stock Symbol for Fagron?

The stock symbol for Fagron is "FAGRO."

What Is the Fagron Market Cap?

As of today, Fagron market cap is 1.51B.

What Is Fagron's Earnings Per Share (TTM)?

The Fagron EPS (TTM) is 1.18.

When Is the Next Fagron Earnings Date?

Fagron will release its next earnings report on 08 Oct 2025.

From a Technical Analysis Perspective, Is FAGRO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Fagron Stock Split?

Fagron has split 1 times.

How Many Employees Does Fagron Have?

Fagron has 3989 employees.

What is the current trading status of Fagron (FAGRO)?

As of 22 Aug 2025, Fagron (FAGRO) is trading at a price of 20.65, with a previous close of 20.70. The stock has fluctuated within a day range of 20.55 to 20.70, while its 52-week range spans from 15.14 to 23.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.